Literature DB >> 18606100

Cardiovascular disease in women.

L Veronica Lee, Joanne Micale Foody.   

Abstract

The rates of cardiovascular disease (CVD) have decreased significantly for men over the past few decades, but similar reductions have not occurred in women. Consequently, CVD remains the leading killer of women in the United States. Men usually develop heart disease earlier than women, but women develop heart disease more rapidly once menopause has occurred. A review of risk factors that are common between men and women demonstrates some notable sex-dependent differences. Many of these changes appear related to the hormonal changes that occur in menopause, such as the development of hypertension, changes in lipid concentrations, and central adiposity. In addition, diabetes is a more significant risk factor for CVD in women than men. Sociologic and physiologic factors need to be considered in treatment of risk factors, such as smoking, lack of exercise, obesity, and depression. Prevention is known to significantly reduce CVD risk, but new goals are being established for women as the sex-dependent differences have become apparent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606100     DOI: 10.1007/s11883-008-0046-7

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  44 in total

1.  Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I.

Authors:  S M Grundy; T Bazzarre; J Cleeman; R B D'Agostino; M Hill; N Houston-Miller; W B Kannel; R Krauss; H M Krumholz; R M Lauer; I S Ockene; R C Pasternak; T Pearson; P M Ridker; D Wood
Journal:  Circulation       Date:  2000-01-04       Impact factor: 29.690

2.  Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  L Mosca; P Collins; D M Herrington; M E Mendelsohn; R C Pasternak; R M Robertson; K Schenck-Gustafsson; S C Smith ; K A Taubert; N K Wenger
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

3.  Hormone replacement therapy and 24-hour blood pressure profile of postmenopausal women.

Authors:  A Butkevich; C Abraham; R A Phillips
Journal:  Am J Hypertens       Date:  2000-09       Impact factor: 2.689

4.  Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study.

Authors:  Alberto Zanchetti; Rita Facchetti; Gian Carlo Cesana; Maria Grazia Modena; Anna Pirrelli; Roberto Sega
Journal:  J Hypertens       Date:  2005-12       Impact factor: 4.844

Review 5.  Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.

Authors:  Lori Mosca; Carole L Banka; Emelia J Benjamin; Kathy Berra; Cheryl Bushnell; Rowena J Dolor; Theodore G Ganiats; Antoinette S Gomes; Heather L Gornik; Clarissa Gracia; Martha Gulati; Constance K Haan; Debra R Judelson; Nora Keenan; Ellie Kelepouris; Erin D Michos; L Kristin Newby; Suzanne Oparil; Pamela Ouyang; Mehmet C Oz; Diana Petitti; Vivian W Pinn; Rita F Redberg; Rosalyn Scott; Katherine Sherif; Sidney C Smith; George Sopko; Robin H Steinhorn; Neil J Stone; Kathryn A Taubert; Barbara A Todd; Elaine Urbina; Nanette K Wenger
Journal:  Circulation       Date:  2007-02-19       Impact factor: 29.690

Review 6.  Obesity, physical inactivity, and risk for cardiovascular disease.

Authors:  Patricia M Dubbert; Teresa Carithers; Anne E Sumner; Krista A Barbour; Bobby L Clark; John E Hall; Errol D Crook
Journal:  Am J Med Sci       Date:  2002-09       Impact factor: 2.378

7.  Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators.

Authors:  F Gueyffier; F Boutitie; J P Boissel; S Pocock; J Coope; J Cutler; T Ekbom; R Fagard; L Friedman; M Perry; R Prineas; E Schron
Journal:  Ann Intern Med       Date:  1997-05-15       Impact factor: 25.391

8.  Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.

Authors:  D Grady; W Applegate; T Bush; C Furberg; B Riggs; S B Hulley
Journal:  Control Clin Trials       Date:  1998-08

9.  Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study.

Authors:  Assiamira Ferrara; Carol M Mangione; Catherine Kim; David G Marrero; David Curb; Mark Stevens; Joseph V Selby
Journal:  Diabetes Care       Date:  2007-10-12       Impact factor: 19.112

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  4 in total

1.  Racial differences in the association between body fat distribution and lipid profiles among reproductive-age women.

Authors:  G M M Hosain; M Rahman; K J Williams; A B Berenson
Journal:  Diabetes Metab       Date:  2010-04-20       Impact factor: 6.041

2.  Racial differences in body fat distribution among reproductive-aged women.

Authors:  Mahbubur Rahman; Jeff R Temple; Carmen Radecki Breitkopf; Abbey B Berenson
Journal:  Metabolism       Date:  2009-06-18       Impact factor: 8.694

3.  A population-based study of cardiovascular disease risk in sexual-minority women.

Authors:  Grant W Farmer; Jennifer M Jabson; Kathleen K Bucholz; Deborah J Bowen
Journal:  Am J Public Health       Date:  2013-08-15       Impact factor: 9.308

Review 4.  Study exploring depression and cardiovascular diseases amongst Arabic speaking patients living in the State of Qatar: Rationale and methodology.

Authors:  Tam Truong Donnelly; Jassim M Al Suwaidi; Awad Alqahtani; Nidal Assad; Najla Abdul Qader; Carolyn Byrne; Rajvir Singh; Tak Shing Fung
Journal:  Glob Cardiol Sci Pract       Date:  2013-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.